Kodiak Sciences Inc. (KOD) vs PTC Therapeutics, Inc. (PTCT)

A side-by-side comparison of Kodiak Sciences Inc. and PTC Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KOD vs PTCT

growth of $100 · dividends reinvested · last 8y
KOD +4521.2% (+61.5%/yr)PTCT +40.6% (+4.3%/yr)KOD compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002020202220242026$4,621$141
KOD PTCT

KOD vs PTCT: by the numbers

  • •KOD is the larger company ($5.96B vs $5.35B market cap).
  • •Both run net losses; KOD's is the smaller (0.00% vs -3.80% net margin).

Metrics side by side

Valuation

MetricKODPTCT
Forward P/EN/A50.40
P/S ratioN/A5.30
P/B ratio97.54N/A
EV / EBITDAN/A29.10

Profitability

MetricKODPTCT
Gross margin0.00%95.85%
Operating margin0.00%49.49%
Net margin0.00%-3.80%
ROE-396.09%N/A
ROIC-115.23%4.59%

Growth (annualized)

MetricKODPTCT
Revenue CAGR (5Y)N/A16.41%
Total return CAGR (5Y)36.19%11.75%

Frequently asked

How have KOD and PTCT total returns compared?
Over the past 5 years, KOD delivered 36.19% and PTCT delivered 11.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.